Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51723-15-0

Post Buying Request

51723-15-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51723-15-0 Usage

General Description

2-Aminobenzaldehyde HCL, also known as o-aminobenzaldehyde hydrochloride, is a chemical compound that consists of a benzene ring with an amino group and an aldehyde functional group. It is used in organic synthesis as a building block for the creation of various pharmaceuticals, dyes, and other chemical compounds. The hydrochloride salt form of 2-aminobenzaldehyde is often preferred for its increased stability, solubility, and ease of handling. It is also used in the research and development of new drugs and as a reagent in chemical reactions due to its versatile reactivity. Additionally, it has applications in the production of fluorescent dyes and as a chemical intermediate for the synthesis of other complex organic compounds. Overall, 2-aminobenzaldehyde HCL is an important chemical in the field of organic chemistry with diverse uses in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 51723-15-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,7,2 and 3 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 51723-15:
(7*5)+(6*1)+(5*7)+(4*2)+(3*3)+(2*1)+(1*5)=100
100 % 10 = 0
So 51723-15-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H7NO.ClH/c8-7-4-2-1-3-6(7)5-9;/h1-5H,8H2;1H

51723-15-0Upstream product

51723-15-0Relevant articles and documents

New Ru(ii) photocages operative with near-IR light: New platform for drug delivery in the PDT window

Al-Afyouni, Malik H.,Rohrabaugh, Thomas N.,Al-Afyouni, Kathlyn F.,Turro, Claudia

, p. 6711 - 6720 (2018)

A series of Ru(ii) complexes bearing the tridentate 2,6-di(quinolin-2-yl)pyridine (dqpy) ligand were designed to undergo photoinduced ligand dissociation with red/near-IR light. The complexes [Ru(dqpy)(L)(CH3CN)]2+, where L = 2,2′-bipyridine (bpy, 1), 4,4′dimethyl-2,2′-bipyridine (Me2bpy, 2), and 1,10-phenanthroline (phen, 3). Complexes 1-3 exhibit red-shifted lowest energy metal-to-ligand charge transfer (MLCT) absorption maxima at ~600 nm, as compared to the corresponding tpy (2,2′;6′,2′′-terpyridine) complexes with MLCT bands at ~565 nm which appear as shoulders to the MLCT bands at ~455 nm. This shift is attributed to the lower energy LUMO afforded by the dqpy ligand when compared to tpy, as evidenced by the shift of the first reduction wave to ~0.3 V more positive potentials in the former. In addition, the lowest MLCT maximum of [Ru(dqpy)(acac)(CH3CN)]+ (4; acac- = acetylacetonate) is observed at 770 nm, attributed to the additional increase in energy of the HOMO afforded by the presence of the π-donating acac- ligand and supported by calculations. Complexes 1-3 undergo ligand substitution upon irradiation with red light, λirr ≥ 610 nm, and the ligand substitution photochemistry of 4 is accessible with near-IR light, λirr ≥ 715 nm and λirr = 735 nm. Complexes 1-4 exhibit similar quantum yields of ligand exchange, ΦL, with 450 and 600 nm irradiation, however, that of 4 is 2-3 times greater than those measured for 1-3. This enhancement is explained by the difference in ligand contributions to the HOMO. Density functional theory calculations predict partial dqpy ππ? character in the MLCT states of 1-3 and a mixed Ru/acac- → dqpy metal/ligand-to-ligand charge transfer (ML-LCT) state in 4. The photoreactivity of 1-4 with tissue-penetrating red and near-IR light, together with their exceptional dark stability (>48 h), makes the new Ru(ii)-dqpy platform ideal for the development of new complexes for photoinduced drug release and for other applications that require broad absorption from the ultraviolet and visible ranges into the near-IR, such as solar energy conversion.

Asymmetric transfer hydrogenation of quinolines using tethered Ru(II) catalysts

Parekh, Vimal,Ramsden, James A.,Wills, Martin

experimental part, p. 1549 - 1556 (2010/11/02)

The first report of an asymmetric transfer hydrogenation, in formic acid/triethylamine, of quinolines is described. Using a Ru(II) catalyst containing a 4-carbon tether, products of up to 73% ee were formed, whilst a Rh(III)-tethered catalyst gave products of up to 94% ee.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51723-15-0